|
|
 |
|
Viewing report
|
|
|
|
Analgesics Market in Nigeria to 2014 (OTC Healthcare)
Datamonitor, Feb 2011, Pages: 27
Introduction
This databook provides key data and information on the Analgesics Market in Nigeria (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
The analgesics category was valued at NGN5,675m ($48.8m) in 2009, representing a CAGR of 2.2% since 2004.
By the end of 2014, the analgesics category will be worth NGN6,199.6m ($53.3m), with an expected CAGR of 1.8% between 2009 and 2014.
The analgesics market was led by paracetamol (representing 43.8% of the total value) followed by aspirin and ibuprofen, with a 24.1% and 16.6% market share, respectively. Other analgesics accounts for the remaining 15.5% share.
Roche Holding AG is the market leader with a 25.6% share of the market.
Reasons to Purchase
-Develop business strategies by understanding the quantitative trends within the Analgesics Market in Nigeria (OTC Healthcare)
-Design effective marketing and sales strategies by identifying key market categories and segments
-Identify key players within the market to plan lucrative M&A, partnerships and agreements
|
|
|
|
